Similar articles

• Reversible interstitial pneumonitis associated with low dose bleomycin.

  O'Neill TJ, Kardinal CG, Tierney LM. O'Neill TJ, et al. Chest. 1975 Aug;68(2):265-7. doi: 10.1378/chest.68.2.265. Chest. 1975. PMID: 50163
• 67Ga accumulation in pulmonary lesions associated with bleomycin toxicity.

  Richman SD, Levenson SM, Bunn PA, Flinn GS, Johnston GS, DeVita VT. Richman SD, et al. Cancer. 1975 Dec;36(6):1966-72. doi: 10.1002/cncr.2820360906. Cancer. 1975. PMID: 54210
• [Bleomycin and skin neoplasms].

  De Bast C, Moriame N, Wanet J, Ledoux M, Achten G, Kenis Y. De Bast C, et al. Arch Belg Dermatol Syphiligr. 1971 Jul-Sep;27(3):233-9. Arch Belg Dermatol Syphiligr. 1971. PMID: 4114613 French. No abstract available.
• Perioperative considerations for patients treated with bleomycin.

  Waid-Jones MI, Coursin DB. Waid-Jones MI, et al. Chest. 1991 Apr;99(4):993-9. doi: 10.1378/chest.99.4.993. Chest. 1991. PMID: 1706974 Review. No abstract available.
• Anticancer drugs: reduction of pulmonary toxicity.

  Scheulen ME. Scheulen ME. Cancer Treat Rev. 1987 Dec;14(3-4):231-43. doi: 10.1016/0305-7372(87)90012-0. Cancer Treat Rev. 1987. PMID: 2449960 Review. No abstract available.